MRLRX
Price
$22.32
Change
-$0.16 (-0.71%)
Updated
Jul 13 closing price
Net Assets
3.94B
VSTSX
Price
$354.42
Change
-$2.83 (-0.79%)
Updated
Jul 13 closing price
Net Assets
2.3T
Interact to see
Advertisement

MRLRX vs VSTSX

MRLRX vs VSTSX Comparison Chart in %
View a ticker or compare two or three
VS
MRLRX vs. VSTSX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MRLRX is a StrongBuy and VSTSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSTSX has more cash in the bank: 2.3T vs. MRLRX (3.94B). VSTSX pays higher dividends than MRLRX: VSTSX (1.07) vs MRLRX (0.24). MRLRX was incepted earlier than VSTSX: MRLRX (24 years) vs VSTSX (10 years). MRLRX (1.21) is less costly to investors than VSTSX (0.01). MRLRX is a more actively managed with annual turnover of: 117.00 vs. VSTSX (3.00). MRLRX has a lower initial minimum investment than VSTSX: MRLRX (100) vs VSTSX (5000000000). VSTSX annual gain was more profitable for investors over the last year : 21.48 vs. MRLRX (16.22). VSTSX return over 5 years is better than : 66.56 vs. MRLRX (10.44).
MRLRXVSTSXMRLRX / VSTSX
Total Expense Ratio0.980.019,800%
Annual Report Gross Expense Ratio1.210.0112,100%
Fund Existence24 years10 years-
Gain YTD13.82311.205123%
Front LoadN/AN/A-
Min. Initial Investment10050000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets3.94B2.3T0%
Annual Yield % from dividends0.241.0723%
Returns for 1 year16.2221.4876%
Returns for 3 years41.7567.0662%
Returns for 5 years10.4466.5616%
Returns for 10 years40.59239.5317%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PWCIX95.22N/A
N/A
Principal Capital Appreciation Inst
PRLAX24.44N/A
N/A
T. Rowe Price Latin America
PACLX37.66N/A
N/A
T. Rowe Price Capital Appreciation Adv
RLIEX20.52N/A
N/A
Lazard International Equity R6
MCYIX16.37-0.51
-3.02%
NYLI Candriam Emerging Markets Eq Cl I